Locations:
Search IconSearch

Neurosciences

online-headache-program_650x450

Online Program Meets Chronic Migraine Patients Where They Are

Eight sessions of education and tailored counseling help patients cope

18-NEU-4011-najmNair-3-650×450
September 28, 2018/Neurosciences/Case Study

Multimodality Evaluation Enables Epilepsy Control in a Patient with Periventricular Nodular Heterotopias

Resulting localization of a single focus paves way for laser ablation

18-NEU-4012-intracranial-aneurysm-650×450
September 19, 2018/Neurosciences/Case Study

Combined Surgical-Endovascular Treatment of an Intracranial Aneurysm in a Patient with ACTA2 Mutation

Direct surgical carotid cutdown overcomes multiple access obstacles

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-NEU-4010-glioblastoma-laser-ablation-650×450
September 17, 2018/Cancer

Tumor Ablation with Chemo-Radiotherapy Consolidation Yields Rare Durable Glioblastoma Remission

No evidence of residual tumor or recurrence at 6.5 years of follow-up

18-NEU-4009-spinal-fusion-scoliosis-650×450
September 12, 2018/Neurosciences/Case Study

Spinal Fusion with Pedicle Screw Instrumentation, Iliac Fixation and Multilevel Osteotomies for Adult Scoliosis

CT navigation, neuromonitoring and blood management help minimize considerable risks

neuro-exam2_650x450 (003)

Is a Detailed Neurologic Physical Examination Always Necessary?

No, but treat every bit of exam info obtained like it matters — because it often will

Lab test

Funding Award Enables First Study to Examine Cognitive Effects of an Alpha-1 Agonist

Cleveland Clinic-developed “compound 3” begins testing in preclinical Alzheimer’s model

BITS-650×450

Thoughtful Tech Adoption Brings Solutions to Rehab Patients

BITS and other innovations enhance OT interventions

18-NEU-5506-Phase-3-Alzheimers-Trials-650×450
August 27, 2018/Geriatrics

Analysis of Alzheimer’s Drug Pipeline Reveals Slow Progress, a Few Bright Spots

Third annual report shows shift toward prevention studies, disease-modifying therapies

BackPage 68 of 78Next

Advertisement

Ad